The Wittrup Lab develops protein
engineering technology and applies it to the discovery of new biopharmaceuticals.
In particular, yeast surface display is used for the directed evolution of protein
expression stability, affinity, and specificity. A particular focus is
on the development of anti-cancer drugs, with quantitative studies of cellular-level
pharmacokinetics and pharmacodynamics.